BofA raises Legence stock price target on data center growth By Investing.com

BofA Securities raised Legence Corp’s price target to $90 from $62 while maintaining a Buy rating, citing above-peer growth and visibility from data center buildout and pharmaceutical reshoring trends. The stock is up 87% year to date and 164% over the past year, trading at $80.58 near its 52-week high of $82.54, while revenue growth has run at 21.5% over the last twelve months. The article also notes recent secondary offerings totaling significant share supply, but the analyst tone remains constructive.

Analysis

LGN is becoming a cleanest-way-pure-play on two capex cycles that usually travel with very different budgets: digital infrastructure and pharma/biotech reshoring. The second-order effect is that this is less about housing more revenue and more about protecting schedule risk for customers that cannot afford delayed commissioning; that tends to support pricing power and backlog quality even if headline construction spending slows. The market is likely underappreciating how tight labor and complex MEP execution convert into operating leverage once utilization stays high.

The setup is also unusually supportive for the supply chain around LGN: firms that can pre-book craft labor, procure long-lead electrical/mechanical components, and bundle maintenance with installation should take share from fragmented regional contractors. That means the competitive moat is not just engineering capability, but balance-sheet capacity and workforce scale. If the company keeps compounding at ~20%+ top line, the valuation can stay elevated for longer than value screens imply, but the multiple is vulnerable if growth normalizes into the low teens.

The main risk is that the stock has already priced in a lot of the next 12-18 months of execution, and recent secondary supply from large holders can create an overhang even if fundamentals remain intact. A miss on backlog conversion, margin pressure from labor inflation, or a pause in data-center orders would likely hit the multiple harder than earnings because the name trades on growth durability. Over a multi-quarter horizon, the consensus may be missing that this is a bottleneck business: when project bottlenecks ease, upside can de-rate fast even if revenue holds up.

Key Decisions for Investors

• Long LGN only on pullbacks toward the prior secondary range, not strength; use a 3-6 month horizon and target a 15-20% upside move if growth stays >20%, with a hard stop if backlog or margin commentary softens.
• For existing holders, sell covered calls 1-2 quarters out against strength to monetize elevated implied volatility; this is the cleaner expression given near-term overvaluation risk and a likely supply overhang.
• Pair trade: long LGN / short a more cyclical general contractor or non-specialized industrial services name over 6-9 months to isolate secular data-center and life-sciences demand from broader construction beta.
• If you want upside with defined risk, buy call spreads rather than outright stock; the risk/reward is better if the market keeps rewarding quality growth but the stock is already near fair-value boundaries.
• Watch for any secondary completion and subsequent lockup expiration as a tactical entry signal; if the stock absorbs supply without breaking trend, that would be a higher-conviction add.